Euronext-listed biotech company TiGenix supports seed round of its spin-out, TR-therapeutics, after its merger with Therosteon to form Arcarios.

Novo Ventures and RiverVest Venture Partners co-lead US-based biotech company Otonomy's second round of funding.

US-based medical device maker ViewRay closes $20m series C round with Siemens Venture Capital in consortium

MedImmune Ventures-backed drugs company NKT gains $12m from consortium across two rounds.

Switzerland-based drugs company Roche will initially provide Aileron with $25m and up to $1.1bn in milestone payments if developments are successful.

Novartis Option Fund joins consortium investing $10m in Anchor Therapeutics' series B round.

Listing of biotechnology group Pacific Biosciences comes a month after bumper series F round.

OriGene Technologies has acquired Blue Heron Biotechnology from its venture investment backers, including Nasdaq-listed Invitrogen.

Chip Clark moves from business development success at Vanda to same role at GlaxoSmithkline-backed Genocea Biosciences.